Cargando…

Successful Treatment of Adenovirus Infection with Brincidofovir in an Immunocompromised Patient after Hematological Stem Cell Transplantation

Immunocompromised patients, including hematopoietic stem cell transplantation (HSCT), HIV, and malnourished patients, are at increased risk for viral infections with high incidences of morbidity and mortality. In HSCT patients, the infection risk is increased until immune reconstitution is re-establ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Van Genechten, T., van Heerden, J., Bauters, T., Dhooge, C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6973187/ https://www.ncbi.nlm.nih.gov/pubmed/31970003 http://dx.doi.org/10.1155/2020/5981289

Ejemplares similares

Rapid Virologic Response to Brincidofovir in Children with Disseminated Adenovirus Infection
por: Chan, Shuk Ying, et al.
Publicado: (2021)

Experimental Treatment of Ebola Virus Disease with Brincidofovir
por: Dunning, Jake, et al.
Publicado: (2016)

Brincidofovir (CMX001) for the Treatment of Severe Adenoviral Pneumonia in Kidney Transplant Recipient
por: Sudhindra, Praveen, et al.
Publicado: (2019)

Brincidofovir Use after Foscarnet Crystal Nephropathy in a Kidney Transplant Recipient with Multiresistant Cytomegalovirus Infection
por: Vial, Romain, et al.
Publicado: (2017)

Sensitivity of Human Mastadenovirus, the Causal Agent of Pharyngoconjunctival Fever, Epidemic Keratoconjunctivitis, and Hemorrhagic Cystitis in Immunocompromised Individuals, to Brincidofovir
por: Hanaoka, Nozomu, et al.
Publicado: (2022)

Life-Threatening Adenovirus Infections in the Setting of the Immunocompromised Allogeneic Stem Cell Transplant Patients
por: Fowler, Cedar J., et al.
Publicado: (2010)

Case report: Brincidofovir-induced reversible severe acute kidney injury in 2 solid-organ transplant for treatment of cytomegalovirus infection
por: Faure, Emmanuel, et al.
Publicado: (2016)

The Role of Brincidofovir in Preparation for a Potential Smallpox Outbreak
por: Foster, Scott A., et al.
Publicado: (2017)

Case report: Brincidofovir-induced reversible severe acute kidney injury in 2 solid-organ transplant for treatment of cytomegalovirus infection: Erratum
Publicado: (2017)

Respiratory adenovirus infections in immunocompetent and immunocompromised adult patients
por: Cederwall, S., et al.
Publicado: (2020)

Pharmacokinetics (PK) and Safety of Intravenous (IV) Brincidofovir (BCV) in Healthy Adult Subjects
por: Wire, Mary Beth, et al.
Publicado: (2017)

A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation
por: Marty, Francisco M., et al.
Publicado: (2018)

Brincidofovir is a robust replication inhibitor against African swine fever virus in vivo and in vitro
por: Guo, Shibang, et al.
Publicado: (2023)

Successful Treatment of Respiratory Syncytial Virus Infection in an Immunocompromised Patient With Ribavirin
por: Mir, Wasey Ali Yadullahi, et al.
Publicado: (2021)

1421. IV Brincidofovir (BCV): Pharmacokinetics (PK) and Safety of Multiple Ascending Doses (MAD) in Healthy Subjects
por: Naderer, Odin, et al.
Publicado: (2018)

Pharmacokinetics and Efficacy of a Potential Smallpox Therapeutic, Brincidofovir, in a Lethal Monkeypox Virus Animal Model
por: Hutson, Christina L., et al.
Publicado: (2021)

Management of Adenovirus in Children after Allogeneic Hematopoietic Stem Cell Transplantation
por: WY Ip, Winnie, et al.
Publicado: (2013)

Analysis of Mutations in the Gene Encoding Cytomegalovirus DNA Polymerase in a Phase 2 Clinical Trial of Brincidofovir Prophylaxis
por: Lanier, E. Randall, et al.
Publicado: (2016)

Disseminated Adenovirus Infection After Combined Liver-Kidney Transplantation
por: Hemmersbach-Miller, Marion, et al.
Publicado: (2018)

Primary Spinal Infections in Patients With Hematologic Immunocompromising Conditions: A Systematic Literature Review
por: Devico Marciano, Naomie, et al.
Publicado: (2023)

Acute liver failure associated with human adenovirus infection after allogeneic hematopoietic stem cell transplantation
por: Lin, Zhimin, et al.
Publicado: (2023)

Breakthrough Bloodstream Infections Caused by Echinocandin-Resistant Candida tropicalis: An Emerging Threat to Immunocompromised Patients with Hematological Malignancies
por: Sfeir, Maroun M., et al.
Publicado: (2020)

Outcomes of Early Administration of Cidofovir in Non-Immunocompromised Patients with Severe Adenovirus Pneumonia
por: Kim, Se Jin, et al.
Publicado: (2015)

Oral Brincidofovir Therapy for Monkeypox Outbreak: A Focused Review on the Therapeutic Potential, Clinical Studies, Patent Literature, and Prospects
por: Imran, Mohd., et al.
Publicado: (2023)

Human Adenovirus-Specific γ/δ and CD8(+) T Cells Generated by T-Cell Receptor Transfection to Treat Adenovirus Infection after Allogeneic Stem Cell Transplantation
por: Dörrie, Jan, et al.
Publicado: (2014)

PB2418: CLINICAL FEATURES AND PROGNOSIS OF ADENOVIRUS INFECTION AFTER HAPLOIDENTICAL DONOR HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: Sun, Wei, et al.
Publicado: (2023)

Life-threatening adenovirus infection in a kidney transplant recipient
por: Barraclough, Katherine, et al.
Publicado: (2009)

Brincidofovir Is Not a Substrate for the Human Organic Anion Transporter 1: A Mechanistic Explanation for the Lack of Nephrotoxicity Observed in Clinical Studies
por: Tippin, Timothy K., et al.
Publicado: (2016)

Disseminated Adenovirus Nephritis After Kidney Transplantation
por: Hatlen, Timothy, et al.
Publicado: (2017)

Successful Treatment of Parainfluenza Virus Respiratory Tract Infection With DAS181 in 4 Immunocompromised Children
por: Waghmare, Alpana, et al.
Publicado: (2015)

Infections in the Immunocompromised
por: Cant, Andrew, et al.
Publicado: (2009)

Transplanting rejuvenated blood stem cells extends lifespan of aged immunocompromised mice
por: Montserrat-Vazquez, Sara, et al.
Publicado: (2022)

Epidemiology and Factors Associated with Treatment Success of Invasive Fungal Infections Among Newly Hematologic Malignancy Patients Receiving Chemotherapy or Hematopoietic Stem Cell Transplant in Thailand
por: Weeraphon, Benjabhorn, et al.
Publicado: (2023)

Quantitative analysis of mRNA-1273 COVID-19 vaccination response in immunocompromised adult hematology patients
por: Haggenburg, Sabine, et al.
Publicado: (2022)

Correction for Hutson et al., “Pharmacokinetics and Efficacy of a Potential Smallpox Therapeutic, Brincidofovir, in a Lethal Monkeypox Virus Animal Model”
por: Hutson, Christina L., et al.
Publicado: (2021)

Respiratory Virus Infections of the Stem Cell Transplant Recipient and the Hematologic Malignancy Patient
por: Fontana, Lauren, et al.
Publicado: (2019)

Lymphocyte reconstitution after allogeneic blood stem cell transplantation for hematologic malignancies
por: Pavletic, ZS, et al.
Publicado: (1998)

Intestinal Adenovirus Shedding Before Allogeneic Stem Cell Transplantation Is a Risk Factor for Invasive Infection Post-transplant
por: Kosulin, Karin, et al.
Publicado: (2018)

298. Successful Treatment of Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Infection in an Immunocompromised Patient
por: Overbeck, Victoria, et al.
Publicado: (2022)

Booster effect after SARS-CoV-2 vaccination in immunocompromised hematology patients with prior COVID-19
por: Piñana, José Luis, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hnii1dikrsobemheiaoej5o5jk